User:IXensor/sandbox

= Xensor Co., Ltd. (company) = iXensor is a digital health technology company that transforms smartphones into lab-grade mobile diagnostic devices with clinical accuracy. It developed the PixoTest Glucose Monitoring System, the world’s first FDA-approved blood testing based on smartphone cameras.

iXensor’s core innovation is PixoTech™, a patented smart color-sensing technology that serves as a cost-effective solution for the rapid detection of various diseases by placing corresponding test trips for different biomarkers.

iXensor was founded in 2012 in Taipei, Taiwan by Alan Tsai, Jerry Chen, and Carson Chen.

iXensor has raised a total of $21.8M in funding over 4 rounds. The latest funding round was raised in 2018 (Series B).

In 2017, iXensor applied PixoTech™ to Women’s health and introduced Eveline, the world’s first AI-powered ovulation prediction kit.

In 2019, iXensor was listed as an emerging stock on the Taipei Exchange (TPEx).